Tuberculosis Pipeline Landscape and Therapeutics Market Review for H2 2016
by Industry Analysis
Comments
Description
Tuberculosis, commonly known as TB, is a bacterial infection that can spread through the lymph nodes and bloodstream to any organ in body. It is most often found in the lungs. The symptoms of tuberculosis range from no symptoms (latent tuberculosis) to symptoms of active disease. Symptoms include overall sensation of feeling unwell; cough, possibly with bloody mucus, fatigue, shortness of breath, weight loss and pain in the chest. Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide Tuberculosis Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Tuberculosis (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
Transcript
Tuberculosis Pipeline Landscape and Therapeutics Market Review for H2 2016
Tuberculosis Pipeline Landscape and Therapeutics Market Review for H2 2016 No of Pages – 393 Publishing Date - November, 2016 Browse detailed TOC, Tables, Figures, and Charts in Global Serial Device Server Consumption 2016 Market Research Report at: http://www.marketresearchhub.com/report/tuberculosis-pipeline-review-h2-2016report.html Tuberculosis, commonly known as TB, is a bacterial infection that can spread through the lymph nodes and bloodstream to any organ in body. It is most often found in the lungs. The symptoms of tuberculosis range from no symptoms (latent tuberculosis) to symptoms of active disease. Symptoms include overall sensation of feeling unwell; cough, possibly with bloody mucus, fatigue, shortness of breath, weight loss and pain in the chest. Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide Tuberculosis Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Tuberculosis (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. Table of Contents Introduction 7 Tuberculosis Overview 8 Therapeutics Development 9 Tuberculosis - Therapeutics under Development by Companies 11 Tuberculosis - Therapeutics under Investigation by Universities/Institutes 16 Tuberculosis - Pipeline Products Glance 19 Tuberculosis - Products under Development by Companies 23 Tuberculosis - Products under Investigation by Universities/Institutes 30 Tuberculosis - Companies Involved in Therapeutics Development 35 Tuberculosis - Therapeutics Assessment 99 Drug Profiles 111 Tuberculosis - Dormant Projects 345 Tuberculosis - Discontinued Products 356 Tuberculosis - Product Development Milestones 357 Appendix 371 List of Tables Number of Products under Development for Tuberculosis, H2 2016 30 Number of Products under Development for Tuberculosis - Comparative Analysis, H2 2016 31 Number of Products under Development by Companies, H2 2016 32 Number of Products under Development by Companies, H2 2016 (Contd..1) 33 Number of Products under Development by Companies, H2 2016 (Contd..2) 34 Number of Products under Development by Companies, H2 2016 (Contd..3) 35 Number of Products under Development by Companies, H2 2016 (Contd..4) 36 Number of Products under Investigation by Universities/Institutes, H2 2016 37 Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..1) 38 Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..2) 39 Comparative Analysis by Late Stage Development, H2 2016 40 Comparative Analysis by Clinical Stage Development, H2 2016 41 Comparative Analysis by Early Stage Development, H2 2016 42 Comparative Analysis by Unknown Stage Development, H2 2016 43 Request for Free Sample Report List of Figures Number of Products Number of Products Number of Products Number of Products under under under under Development for Tuberculosis, H2 2016 30 Development for Tuberculosis - Comparative Analysis, H2 2016 31 Development by Companies, H2 2016 32 Investigation by Universities/Institutes, H2 2016 37 Comparative Analysis by Late Stage Development, H2 2016 40 Comparative Analysis by Clinical Stage Development, H2 2016 41 Comparative Analysis by Early Stage Products, H2 2016 42 Assessment by Monotherapy Products, H2 2016 120 Assessment by Combination Products, H2 2016 121 Report Details – Date of Publishing – November, 2016 No of Pages – 393 Single User License – $2000 Multiple User License – $4000 Buy Report Now! About Market Research HUB : Market Research HUB is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments. Contact– 90 State Street, Albany, NY 12207, United States Toll Free : 866-997-4948 (US-Canada) Tel : +1-518-621-2074 Email : mailto:[email protected] Website : http://www.marketresearchhub.com/